Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis-Reference-Cited by-同舟云学术

Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis

Published:2016-10 Issue:4 Volume:65 Page:769-775
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Hartl Johannes,Denzer Ulrike,Ehlken Hanno,Zenouzi Roman,Peiseler Moritz,Sebode Marcial,Hübener Sina,Pannicke Nadine,Weiler-Normann Christina,Quaas Alexander,Lohse Ansgar W.,Schramm Christoph

Funder

Deutsche Forschungsgemeinschaft

YAEL Foundation

Helmut and Hannelore Greve Foundation

Publisher

Elsevier BV

Subject

Hepatology

Reference37 articles.

1. Autoimmune hepatitis: a life-long disease;Weiler-Normann;J Hepatol,2013

2. Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission;van Gerven;J Hepatol,2013

3. Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis;Hartl;J Hepatol,2015

4. Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis;Soloway;Gastroenterology,1972

5. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials;Lamers;J Hepatol,2010

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis.;JHEP Reports;2024-09

2. Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R‐LIVER);Liver International;2024-07-22

3. Previous hepatitis E virus infection is associated with increased liver stiffness in patients with autoimmune hepatitis;Polish Archives of Internal Medicine;2024-04-23

4. Comparative value of controlled attenuation (CAPc) and continuous controlled attenuation (CAP) parameters for different stages of non-alcoholic fatty liver disease;Experimental and Clinical Gastroenterology;2024-03-26

5. Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline;Hepatology;2024-03-15